VP, GEMAP

The Vice President GEMAP is responsible for the development of global market access strategies, global evidence plans and generation including health economics and outcomes research and global pricing strategies for the entire CSL Behring portfolio, both in-line and pipeline. These key strategies are developed in alignment with global business objectives during development, launch and life cycle management of the portfolio. This position ensures ongoing assessment and adaption of strategies to maintain an optimal portfolio and market access and works collaboratively with the Therapeutic Area (TA) Commercial Co-leads as well as the regional heads of NA/EU/APAC/ICO and with Global Healthcare Policy & External Affairs to ensure smooth cooperation between HQ and our regional colleagues.

Develops global market access strategies and ongoing assessment and adaption of strategies from product development through launch and life cycle management including pricing, reimbursement, value proposition and messaging, evidence generation and payer strategies.  Monitors trends and developments in order to proactively identify needs and actions to support the value proposition of our portfolio across a multitude of payer environments.

Ensures integration of market access and payer perspectives into product development plans at all stages of development in close collaboration with R&D and in accordance with the Stage Gate system.

Provide overall product value demonstration strategies and evidence generation including maximization of health economics, HTA and quality of life outcomes and development of global value dossiers.

Develops global pricing strategies and ongoing assessment and adaptation of strategies to ensure an optimal balance of revenue, volume, margin and access across the portfolio and geographies. 

Provides global oversight and support for the affiliates in fulfilling their market access ambitions, achieving optimal pricing and revenue for CSL Behring products, and maintaining reimbursement and access in the context of the evolving Market Access landscape and increasing access restrictions by payers.

Our Benefits

We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.

CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Learn more about CSL Behring.

As a global organisation with employees in 35+ countries, CSL embraces diversity, equity and inclusion. Learn more about Diversity, Equity & Inclusion at CSL.